REPROCELL Corporate News

Histocell obtains AEMPS authorisation and GMP certification for its new manufacturing plant for cell therapy and associated biological medicinal products in Larrabetzu

REPROCELL's clinical stem cells manufacturing partner Histocell has obtained AEMPS authorisation and GMP certification for its new manufacturing plant, that is located in Larrabetzu, Spain. Histocell's manufacturing plant  produces cell therapy and associated biological medicinal products.

Read Histocell's press release (offsite )

See REPROCELL's GMP MSC production services page for more information.

Subscribe to receive updates from REPROCELL

Tagged

Clinical capabilities Stem cells

Stem cell and drug discovery scientists around the world are using REPROCELL’s services and products in their preclinical and clinical research.

 More about REPROCELL

REPROCELL Corporate News